Alzheimer’s Drug Achieves Phase 3 Success

2026-04-02T01:50:33+02:00

A groundbreaking Alzheimer's drug has achieved significant Phase 3 trial success, offering new hope in the quest for an Alzheimer's cure and improved dementia treatment. Discover what this medical breakthrough means.

Alzheimer’s Drug Achieves Phase 3 Success2026-04-02T01:50:33+02:00

FDA Halts AI Diagnostic Rollout Over ‘Black Box’ Bias: The Future of Health Tech on Hold

2026-03-29T18:43:41+02:00

The FDA has halted a significant AI-powered diagnostic tool rollout, citing 'black box' bias concerns that raise critical questions about fairness and transparency in medical artificial intelligence. This pivotal moment is reshaping the future of health tech.

FDA Halts AI Diagnostic Rollout Over ‘Black Box’ Bias: The Future of Health Tech on Hold2026-03-29T18:43:41+02:00
Go to Top